e-learning
resources
Munich 2014
Sunday, 07.09.2014
COPD exacerbations
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Analysis of the microbiota of sputum samples from patients with chronic obstructive pulmonary disease
N. Shen, J. Erb-Downward, Y. Du, J. Wang, G. Huffnagle, M. Gyetko, B. He (Beijing, China; Ann Arbor, United States Of America)
Source:
International Congress 2014 – COPD exacerbations
Session:
COPD exacerbations
Session type:
Poster Discussion
Number:
523
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Shen, J. Erb-Downward, Y. Du, J. Wang, G. Huffnagle, M. Gyetko, B. He (Beijing, China; Ann Arbor, United States Of America). Analysis of the microbiota of sputum samples from patients with chronic obstructive pulmonary disease. Eur Respir J 2014; 44: Suppl. 58, 523
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
A 62-year-old man with scanty mucoid sputum
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Dynamics of sputum antimicrobial peptide levels in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2015 – Infection in COPD: different aspects of the host/pathogen balance
Year: 2015
Frequency of osteoporosis and pulmonary diffusing capacity in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Nutritional status in chronic obstructive pulmonary disease
Source: International Congress 2014 – Comorbidities
Year: 2014
The systemic inflammation and factors of coagulation in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – COPD markers
Year: 2014
Prediction of chronic renal failure in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Chronic obstructive pulmonary disease exacerbations: Impact of the GOLD stage or the presence of bronchiectasis on sputum microbiology
Source: Annual Congress 2013 –Research questions on how viruses affect the respiratory system
Year: 2013
Validation of a four point sputum colour chart in chronic obstructive pulmonary disease
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
Comparison of blood eosinophils and plasma periostin in stable and non-stable chronic obstructive pulmonary disease: How we can improve the management of our patients
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
Features of systemic inflammation in patients with stable COPD
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Infective exacerbations of COPD. Relation between the bacteriologic etiology and severity of the disease
Source: International Congress 2014 – COPD markers
Year: 2014
Detection of chronic obstructive pulmonary disease (COPD) in patients with cardio-vascular system pathology
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
Early phenotypes of chronic obstructive pulmonary disease (COPD)
Source: International Congress 2015 – Different data in COPD
Year: 2015
Exacerbations in patients with chronic obstructive lung disease (COPD) and concomitant asthma
Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Year: 2014
Etiology of exacerbations in severe COPD patients with bronchial chronic colonization by pseudomonas
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013
Pulmonary diffusing capacity and the risk of fractures in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – COPD markers
Year: 2014
Assessment of treatment efficiency in patients with chronic obstructive pulmonary disease combined with gastroesophageal reflux disease during treatment with melatonin
Source: International Congress 2014 – Clinical presentations
Year: 2014
The role of inflammatory biomarkers and health related quality of life questionnaires in distinction of exacerbation and stable chronic obstructive pulmonary diseases
Source: International Congress 2014 – Markers
Year: 2014
Relationship between dyspnea and depression in the elderly patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Antibiotic resistance in ambulatory patients with chronic obstructive pulmonary disease–clinical signs
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013
Effect of roflumilast on morphological changes in mucous membrane of bronchi in patients with severe chronic obstructive pulmonary disease
Source: International Congress 2014 – Predictors
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept